Inhaltsbereich
2022
- Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immmunogenicity and protective capacity.
Meyer zu Natrup C., Tscherne A., Dahlke C., Ciurkiewicz M., Shin D.-l., Fathi A., Rohde C., Kalodimou G., Halwe S., Limpinsel L., Schwarz J.H., Klug M., Esen M., Schneiderhan-Marra N., Dulovic A., Kupke A., Brosinski K, Clever S, Schünemann L.-M., Beythien G., Armando F., Mayer L., Weskamm L.M., Jany S., Freudenstein A., Tuchel T., Baumgärtner W., Kremsner P., Fendel R., Addo M.M., Becker S., Sutter G., Volz A.
J Clin Invest. 2022 Oct 27; e159895. doi: 10.1172/JCI159895.
- Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine.
Weskamm L.M., Fathi A., Raadsen M.P., ..., Sutter G., Dahlke C., Addo M.M.
Cell Rep Med. 2022 Jul 19;3(7):100685. https://doi.org/10.1016/j.xcrm.2022.100685
- Increased neutralization and IgG epitope identification aftre MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
Fathi A., Dahlke C., Krähling V., Kupke A., Okba N.M.A., Raadsen M.P., Heidepriem J., Müller M.A., Paris G., Lassen S., KLüver M., Volz A., Koch T., Ly M.L., Friedrich M., Fux R., Tscherne A., Kalodimou G., Schmiedel S., Corman V.M., Hesterkamp T., Drosten C., Loeffer F.F., Haagmans B.L., Sutter G., Becker S., Addo M.M.
Nature Communications (2022) Jul 19;13(1):4182. https://doi.org/10.1038/s4167-022-31557-0
- Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.
Kupke A., Volz A., Dietzel E., Freudenstein A., Schmidt J., Shams-Eldin H., Jany S., Sauerhering L., Krähling V., Serra M.G., Herden C., Eickmann M., Becker S., Sutter G.
Vaccines 2022 Mar 29;10(4):533. https://doi.org/10.3390/vaccines10040533
Servicebereich